Inspire Medical Systems, Inc. Announces Third Quarter 2020 Financial Results and Updates 2020 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Inspire Medical Systems (INSP) Tops Q3 EPS by 33c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus
November 2, 2020 5:01 PM ESTInspire Medical Systems (NYSE: INSP) reported Q3 EPS of ($0.39), $0.33 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $22.75 million.
Recent Business Highlights
Generated revenue of $35.8 million in the third quarter of 2020, a 72% increase over the same quarter last yearReported gross margin of 85.5% in the third quarter of 2020, an increase over the 83.4% reported in the same quarter last yearActivated 42 new centers in the third quarter of 2020, bringing the total to 370 U.S. medical centers implanting Inspire therapyCreated... More